PMID: 8964958Jan 1, 1996Paper

Management of hematologic malignancies during pregnancy

Journal de gynécologie, obstétrique et biologie de la reproduction
F MaloiselF Oberling

Abstract

Hodgkin's disease, non-Hodgkin lymphoma or leukemia occurring in a pregnant patient is a rare event. Diagnosis of hematologic malignancies in a pregnant woman usually poses a quandrum of psychological, ethical and medical considerations. All of these situations require a multidisciplinary team. Adequate staging and treatment of hematologic malignancies are complicated by the pregnancy. In the first trimester, termination of the pregnancy should be considered in order to provide the best outcome for the woman and fetus. In this review we have focused on the use of chemotherapy for the pregnant patient. This review reveals that the use of chemotherapy resulted in both objective disease remissions and the subsequent delivery of normal infant.

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

Clinical Oncology : a Journal of the Royal College of Radiologists
C N Okechukwu, J Ross
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology
T StefosV Dousias
Nederlands tijdschrift voor geneeskunde
R Somers, P van Heerde
© 2021 Meta ULC. All rights reserved